PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Microtome Improves Efficiency for Parkinson's Disease and Multiple Sclerosis Research - Sectioning instrumentation selected by UK tissue bank for enhanced quality and productivity (NYSE: TMO)
Thermo Fisher Scientific Microtome Improves Efficiency for Parkinson's Disease and Multiple Sclerosis Research

 

NewswireToday - /newswire/ - Runcorn, Cheshire, United Kingdom, 2010/07/16 - Sectioning instrumentation selected by UK tissue bank for enhanced quality and productivity (NYSE: TMO).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that the Parkinson's UK and MS Society Tissue Bank, which supplies the research community with high-quality Parkinson's disease and multiple sclerosis (MS) tissues, is using its Finesse Microtome for the preparation of tissue samples for its neuropathological examinations. The implementation of the Thermo Scientific Finesse Microtome in the joint tissue bank has made diagnosis easier and accelerated throughput. In addition, the quality and the size of the sections produced has been enhanced, enabling the tissue bank to fully maintain the anatomical orientation of the samples that it prepares, which improves both reliability and speed of diagnosis.

The tissue bank, jointly funded by Parkinson's UK and the MS Society, procures brain, spinal cord and other tissues that are bequeathed by donors, making them available to scientists investigating the causes of and treatments for diseases. Vital information about how the brain and spinal cord are damaged in Parkinson's disease and MS can be obtained by studying the tissue from people affected by these diseases and comparing it to unaffected donors. The donation of tissue and the preparation of tissue for research are therefore fundamental to furthering understanding of the causes of the diseases and for developing more effective treatments. The tissue bank's work is reliant on members of the public joining its brain donor registry, and it is imperative that more people sign up.

Prior to the implementation of the Thermo Scientific Finesse Microtome, the tissue bank had been experiencing challenges with the quality of the samples that were being produced using its existing microtome. The instrument could only handle small block sizes, which significantly impacted upon the quality of the sections that were being created. Samples often had to reside across a number of different slides, which resulted in significant loss of tissue view. According to the tissue bank, one of the fundamental factors in deciding to implement the Finesse Microtome was the instrument's capability to handle larger block sizes. The larger blocks enable the tissue bank's neuropathologists to view important adjacent brain structures in one section, avoiding the need to switch between different slides. This has improved the speed and reliability of diagnosis. The tissue bank can also now supply larger block tissue sections to researchers. In addition, the Finesse Microtome provides the tissue bank with benefits of ease-of-use and high performance.

Dr. David Dexter, one of the scientific directors at the tissue bank, comments: "The quality of the tissue samples that we produce greatly impacts on the performance of the tissue bank and, ultimately, the quality of the research. Since bringing the new instrument into the laboratory, its capability to handle larger blocks as well as the enhanced quality of the sections it produces has meant that our neuropathologist's ability to diagnose cases has dramatically improved."

Giulio Cerroni, vice president of Thermo Fisher Scientific commercial operations in Europe, the Middle East and Asia Pacific for anatomical pathology, said "At Thermo Fisher, we are working to provide instrumentation that will improve our customer's workflows and make the day-to-day processes that they undertake easier. The work of the tissue bank is vital to furthering understanding of the diseases and it is great to see that the instrument is achieving our goals by improving the diagnosis of cases."

Thermo Scientific is part of Thermo Fisher Scientific Inc., the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (thermofisher.com) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.

For further press information please contact: Laura Browne, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom T: +44 1477 539539 F: +44 1477 539 540 E: pathology[.]scottpr.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Microtome Improves Efficiency for Parkinson's Disease and Multiple Sclerosis Research

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Michelle Valentine 
+44 (0)800 018 9396 sales.ap.uk[.]thermofisher.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  1Click Games





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)